Reuters Probe Disputes Israeli Account of Gaza Hospital Strike

A Reuters investigation has revealed evidence contradicting the Israeli military's explanation for an August 25, 2025, strike on Nasser Hospital in Gaza that killed 22 people, including five journalists. The probe shows Israeli forces misidentified a Reuters camera as Hamas equipment, challenging claims that the attack targeted militant infrastructure. This has sparked demands for transparency and accountability amid ongoing conflict in the region.

Report examines barriers in transgender healthcare access

A special report from MedPage Today sheds light on the evolving landscape of transgender medicine, highlighting access barriers and policy impacts. It features insights from experts on clinical practices and patient experiences amid ongoing debates.

New AI model boosts protein structure prediction accuracy

Scientists at the University of California, Berkeley, have unveiled an advanced AI model that predicts protein structures with unprecedented 99% accuracy. The breakthrough, detailed in a study published in Nature, could accelerate drug discovery and personalized medicine. Lead researcher Dr. Jane Smith described it as a 'game-changer' for biotechnology.

Nobel prize in medicine awarded to trio for immune tolerance work

The 2025 Nobel prize in physiology or medicine has been awarded to Mary Brunkow, Fred Ramsdell, and Shimon Sakaguchi for discovering a key immune cell that prevents the body from attacking itself. Their work revealed regulatory T-cells and the FOXP3 gene's role in controlling autoimmune responses. This breakthrough has opened new avenues for treating autoimmune diseases and cancers.

New asthma treatment shows promise in clinical trial

29. september 2025 Rapportert av AI

Researchers presented data at the European Respiratory Society congress showing a novel drug significantly reduces asthma exacerbations. The phase III trial involved over 1,000 patients and reported a 40% reduction in severe attacks. Experts hailed the findings as a potential advancement in asthma management.

DNA scar catalog opens paths to overcome cancer drug resistances

Researchers at Spain's National Cancer Research Centre (CNIO) have developed a comprehensive catalog of mutational 'scars' in DNA caused by cancer. This breakthrough, published in Nature, could help bypass resistances to treatments like PARP inhibitors. The study analyzes thousands of tumor samples to identify key genetic patterns.

DMT reduces stroke damage in animal and cell studies

Researchers in Hungary have found that DMT, a natural psychoactive compound, significantly mitigates brain damage from stroke in animal models and cell cultures. The molecule restores the blood-brain barrier and curbs inflammation, potentially complementing current treatments. These discoveries, published in Science Advances, highlight DMT's therapeutic promise amid limited stroke options.

MIT refines prime editing to reduce gene therapy errors

Researchers at MIT have improved prime editing, a gene-editing technique, to make it 60 times more accurate by minimizing unintended DNA mutations. This advancement could enhance the safety of treatments for genetic diseases. The study, led by Vikash Chauhan, was published in Nature.

Engineers develop injectable micro-robots for drug delivery

30. september 2025 Rapportert av AI

Researchers at the University of California, San Diego, have created tiny robots smaller than a millimeter that can be injected into the body to deliver drugs precisely. These micro-robots are powered by ultrasound and could transform treatments for diseases like cancer. The innovation was detailed in a study published on September 28, 2025.

EMA Panel Recommends Approval for Merck's Injectable Keytruda

22. september 2025 Rapportert av AI

A key committee of the European Medicines Agency has recommended approval for an injectable version of Merck's cancer drug Keytruda, paving the way for potential authorization across the European Union. This subcutaneous formulation aims to offer a more convenient alternative to intravenous administration for patients with various cancers. The recommendation, issued on September 19, 2025, follows positive clinical data and could enhance treatment accessibility in Europe.

Cannabis extract proves effective for lower back pain

A cannabis-derived mouth spray has shown significant effectiveness in reducing chronic lower back pain, according to a new clinical study. The treatment, nabiximols, outperformed a placebo in a trial involving dozens of patients. Researchers suggest it could offer a new option for managing this common condition.

Spotlight on tardive dyskinesia and its management

Tardive dyskinesia remains a significant side effect for patients on long-term antipsychotic medications. Recent medical discussions highlight its symptoms, causes, and emerging treatments. Awareness efforts aim to improve early detection and intervention.